Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid
Open Access
- 1 April 2009
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 37 (4) , 787-793
Abstract
The objective of the present study was to examine the accuracy of using unbound brain concentration determined by a brain homogenate method (Cub), cerebral spinal fluid concentration (CCSF), and unbound plasma concentration (Cup) as a surrogate for brain interstitial fluid concentration determined by brain microdialysis (Cm). Nine compounds—carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental—were selected, and each was administered as an intravenous bolus (up to 5 mg/kg) followed by a constant intravenous infusion (1–9 mg/kg/h) for 6 h in rats. For eight of the nine compounds, the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub. The CCSFs of eight of the nine compounds were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm. The Cups of five of the nine compounds were within 3-fold of their Cm; four compounds (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm. In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compounds tested. The Cups were within 3-fold of Cm for lipophilic non–P-glycoprotein (–P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates. The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concentrations within 3-fold of error in drug discovery and development settings.Keywords
This publication has 23 references indexed in Scilit:
- On The Rate and Extent of Drug Delivery to the BrainPharmaceutical Research, 2007
- In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular FluidsDrug Metabolism and Disposition, 2007
- Microdialysis in the Human Brain and its Potential Role in the Development and Clinical Assessment of DrugsCurrent Medicinal Chemistry, 2007
- AAPS-FDA Workshop White Paper: Microdialysis Principles, Application and Regulatory PerspectivesPharmaceutical Research, 2007
- EVALUATION OF THE UTILITY OF BRAIN SLICE METHODS TO STUDY BRAIN PENETRATIONDrug Metabolism and Disposition, 2006
- Dynamics of CNS Barriers: Evolution, Differentiation, and ModulationCellular and Molecular Neurobiology, 2005
- THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODELDrug Metabolism and Disposition, 2005
- Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran SymposiumNeuro-Oncology, 2004
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- Blood‐brain barrier transport and brain distribution of morphine‐6‐glucuronide in relation to the antinociceptive effect in rats – pharmacokinetic/pharmacodynamic modellingBritish Journal of Pharmacology, 2001